Tokyo court rejects Shire claim against Roche haemophilia drug

Chugai, which is 60 percent Roche-owned and which developed Hemlibra, said it expected no change to its financial prospects due to the ruling. “Tokyo District Court rendered a decision in favour of Chugai’s claim,” Chugai said on its website. “(Shire’s …
( read original story …)


Related Post

How The Ritz-Carlton Hotel Company Serves Up Authe...
views 131
All of that history and heritage now inform a simp...
Japan’s Lucrative Market for Doing Business:...
views 108
Forty industry experts, innovators, healthcare com...
Woman set on fire in Japan restaurant
views 189
TOKYO: A man set a woman on fire following an argu...
Japanese PM touring Asia’s youngest, growing econo...
views 206
SINGAPORE - Japanese Prime Minister Shinzo Abe beg...
North Korea talks deepen Japan’s dilemma
views 37
Japan was clearly marginalized in the run-up to an...
Dior unveils new Tokyo store and fresh looks
views 261
Christian Dior launches its new Tokyo store with r...
Toshiba Adds Nuance's AutoStore and Equitrac ...
views 217
TOKYO--(BUSINESS WIRE)--Toshiba Tec Corporation (T...
Looking for a Free Ticket to Japan? Visit the Lamu...
views 38
The need for decent housing with affordable prices...
Japan's mouthwatering school lunch program is...
views 206
Japanese school lunches aren't synonymous with "my...
Tokyo police arrest man after multiple bodies foun...
views 156
Tokyo police have arrested a man after finding "mu...